$OCGN

Ocugen Inc

  • NASDAQ CAPITAL MARKET
  • Health Technology
  • Biotechnology
  • Pharmaceuticals: Major
  • Manufacturing
  • Sanitary Paper Product Manufacturing

PRICE

$6.8 โ–ฒ1.341%

Extented Hours

VOLUME

7,098,297

DAY RANGE

6.67 - 6.93

52 WEEK

0.2501 - 18.77

Join Discuss about OCGN with like-minded investors

profile
@HeyShoe #droscrew
recently

RECAP 6/29 Chatter: $BKD + For Sale (Dealreporter) $OCGN + NIH COvaxin article $COIN + Crypto Savings account $SHOP - App Store commissions

67 Replies 13 ๐Ÿ‘ 12 ๐Ÿ”ฅ

BA
@balzun #ivtrades
recently

$OCGN doing OCGN things

102 Replies 7 ๐Ÿ‘ 14 ๐Ÿ”ฅ

profile
@Chano #StockTraders.NET
recently

$OCGN $WKHS surprising come backs from today

87 Replies 6 ๐Ÿ‘ 13 ๐Ÿ”ฅ

VA
@Valckrie #StockTraders.NET
recently

anyone know why ocgn is moving

96 Replies 10 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

OCGN 06/18 8 call .47 3 contracts for the gap fill

133 Replies 12 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@marketjay #marketassasins
recently

OCGN moving

60 Replies 6 ๐Ÿ‘ 13 ๐Ÿ”ฅ

VA
@Valckrie #StockTraders.NET
recently

OCGN another life :)

116 Replies 15 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@viking #StockTraders.NET
recently

Upside: -NOVN +32% (reports positive topline results from pivotal Phase III trial of SB206 in patients with molluscum contagiosum) -PGEN +28% (announces positive topline results from Phase 1b/2a study of AG019 ActoBiotics, a Novel Therapy designed to address the underlying cause of Type 1 Diabetes; primary endpoints were met) -GENE +15% (US Patent Office grants foundational pharmacogenomic patent) -MX +15% (confirms 21% improved rival bid of $35/shr cash unsolicited proposal from Cornucopia Investment Partners) -ZDGE +9.5% (earnings, guidance) -ATC +8.4% (MKS Instruments said to have approached Atotech for acquisition) -ADMP +5.9% (provides update on clinical trial start-up progress for tempol in the treatment of COVID-19) -RFP +5.6% (announces $1/share Special Dividend, and $50M in lumber investments) -PLAY +5.3% (earnings, guidance) -AUTL +5.1% (presents new data on obe-cel in r/r Indolent B cell lymphomas and gives an update of obe-cel in r/r Adult ALL at the European Hematology Association Virtual Congress) -MBIO +5.0% (announced updated interim Phase 1/2 data for MB-106) -TYME +5.0% (comprehensive strategic review identified breast cancer as a priority indication for development, a focus on second-line pancreatic cancer, and continuation of trial in high-risk sarcomas) -LIFE +2.5% (presents poster demonstrating functional selectivity of second Anti-NRP2 Antibody) -OCGN +1.4% (Roth Capital broker downgrade) -AVO +1.3% (earnings, guidance) Downside: -ORPH -52% (application for MIPLYFFA under priority review with FDA, expected Prescription Drug User Fee Act action date of June 17; company not aware for reason for stock volatility) -VRTX -14% (reports primary endpoint achieved in Phase 2 Study of VX-864 in Alpha-1 Antitrypsin Deficiency but magnitude of treatment effect observed unlikely to translate into substantial clinical benefit) -CVAC -11% (downside momentum) -INCY -4.0% (FDA extendes the New Drug Application review period for ruxolitinib cream for the treatment of atopic dermatitis) -ADC -3.9% (prices 4.0M shares at implied $71.50/shr to raise $286M) -SNOW -3.7% (provides 2029 financial targets) -ELY -3.6% (to join S&P MidCap 400) -LTHM -3.2% (prices 13M shares at $17.50/shr) -AGNC -3.1% (reports tangible net book value) -RCL -2.1% (two guests aboard Celebrity Millennium test positive for COVID during required end-of-cruise testing) -CHWY -1.4% (earnings, guidance)

97 Replies 15 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

$OCGN 7.50's o/u key

135 Replies 12 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

starter ss on $OCGN here

44 Replies 12 ๐Ÿ‘ 7 ๐Ÿ”ฅ

SO
@soheil.n #StockTraders.NET
recently

watchlist: main: $AHT, $CLNE, $GEO...others: $FCEL/$PLUG, $ATOS, $CLF, $OCGN

138 Replies 12 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@viking #StockTraders.NET
recently

Upside: -ZIVO +24% (momentum following LD Micro Virtual conference) -SNGX +16% (receives Pediatric Investigational Plan Waiver for HyBryteโ„ข in CTCL from the European Medicines Agency) -OXM +14% (earnings, guidance) -RH +8.0% (earnings, guidance) -SIG +7.7% (earnings, guidance; reinstates dividend at lower level) -ASAN +6.9% (momentum) -ENZ +5.6% (earnings) -VOR +4.4% (entered into a multi-year strategic collaboration with Abound Bio and license agreement to research both single- and multi-targeted CAR-T treatments) -TLYS +3.4% (declares $1.00/shr special cash dividend) -GEF +1.7% (earnings, guidance) Downside: -OCGN -40% (to pursue a BLA path in the US for its COVID-19 vaccine candidate; no longer pursuing EUA) -MTLS -14% (prices public offering of 4.0M ADS at $24.0 each for total gross proceedings of $96M) -KLXE -13% (earnings, guidance) -CELH -9.9% (prices 6.5M share offering at $62.50/shr) -FCEL -9.8% (earnings, guidance) -LAKE -7.4% (earnings) -GME -6.5% (earnings, guidance; discloses SEC document request related to investigation of trading activity in GME securities) -IMBI -5.4% (prices offer of 4.8M shares at $9.00/shr for total gross proceedings of $43.5M) -LTHM -3.4% (files to sell 12.5M shares via GS and JPM) -FSLY -2.3% (Oppenheimer Cuts FSLY to Perform from Outperform) -REVG -2.1% (files to sell 7.5M common share secondary offering)

45 Replies 12 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@cespinoza9801 #ivtrades
recently

$ocgn down

112 Replies 15 ๐Ÿ‘ 13 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

some one on $OCGN is cheating I mean they already used up those 9 lives, they deff use cheats! > @maletone said: $ocgn ...this will be back above $12 again stock has like 9 lives

131 Replies 7 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@Bags #Dark Pool Charts
recently

$OCGN 45% plunge on good news, full vaccine approval

59 Replies 8 ๐Ÿ‘ 8 ๐Ÿ”ฅ

profile
@Bags #Dark Pool Charts
recently

Oh my $OCGN

98 Replies 15 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$ocgn ...this will be back above $12 again stock has like 9 lives

137 Replies 15 ๐Ÿ‘ 13 ๐Ÿ”ฅ

XX
@xX_Drip_Gawd_Xx #StockTraders.NET
recently

Watch $OCGN for the big fake offers. I already saw one disappear today. There is one @ $10 RN

138 Replies 10 ๐Ÿ‘ 14 ๐Ÿ”ฅ

BR
@BrittJ #StockTraders.NET
recently

I had lines starting at 10 last month will wait for higher > @xX_Drip_Gawd_Xx said: $OCGN

77 Replies 12 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@Bags #Dark Pool Charts
recently

DP, take a look at $OCGN ๐Ÿ‘€

46 Replies 6 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@viking #StockTraders.NET
recently

OCGN Seeing weekly call activity

102 Replies 14 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@TradesbytheBell #Trades by the Bell LLC
recently

@everyone Swing Trade

77 Replies 11 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@DarkPoolAlgo #Dark Pool Charts
recently

/*============================================= = MORNING UPDATE - Thursday 05/27/21 = =============================================*/ Futures Up/Down % Last Dow -9.00 0.03% 34,271 S&P 500 -8.25 0.20% 4,184 Nasdaq -54.50 0.40% 13,646 Stock futures are edging slightly lower ahead of a busy morning of economic data, as investors await monthly GDP (2nd estimate for Q1 with estimate about 6.4% โ€“ in-line with prior reading), jobless claims data, durable goods and pending home sales. The narrative remains the same day after day as the U.S. economy continues to show improvement/rebound from pandemic lows, which has raised concerns over rising inflation and fears the Fed could pull back on its asset purchases/monetary policy โ€“ but most official have said over the last week they donโ€™t feel it will be necessary to change course since rising price pressures likely will just be transitory. Market fears remain non-existent again as the CBOE Volatility Index (VIX) comes into the day below the 18 level (was above 27 just over a week ago). In Asian markets, The Nikkei Index fell -93 points to 28,549, the Shanghai Index rose 15 points to 3,608 and the Hang Seng Index fell -52 points to 29,113. In Europe, the German DAX is down over 40 points to 15,400, while the FTSE 100 is down a few points to 7,015. Stocks edged higher on Wednesday, with the SmallCap Russell 2000 index leading (up nearly 2%), and the tech heavy Nasdaq Composite, as markets were once again spurred by further reassuring talk from Federal Reserve officials that spiking inflation will be โ€œtransitoryโ€ with Treasury yields remaining lower. Fed Vice Chair Randal Quarles was the latest Fed official to ease worries about inflation. Outside of SmallCap and tech, momentum related sectors fueled the rally with social media โ€œmemeโ€ stocks surging ($GME, $AMC, $EXPR, $KOSS), along with electric vehicle names and Bitcoin leveraged stocks. Events Calendar for Today 8:30 AM EST Gross Domestic Product (GDP) Q1 (2nd) โ€ฆest. 6.5% 8:30 AM EST GDP Price Deflator Q1 (2nd) โ€ฆest. 4.1% 8:30 AM EST GDP Consumer Spending for Q1 (2nd) 8:30 AM EST Core PCE Prices for Q1โ€ฆest. 2.3% 8:30 AM EST PCE Prices Prelim for Q1 8:30 AM EST Weekly Jobless Claimsโ€ฆest. 425K 8:30 AM EST Continuing Claimsโ€ฆest. 3.68M 8:30 AM EST Durable Goods for Aprilโ€ฆest. 0.7% 8:30 AM EST Durable Goods Ex Transports for Aprilโ€ฆest. 0.8% 10:00 AM EST Pending Home Sales MoM for Aprilโ€ฆest. 0.8% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM EST Kansas City Fed Manufacturing for May Earnings Calendar: Earnings Before the Open: $AMWD, $BBY, $BURL, $DG, $DLTR, $DXLG, $GCO, $HLNE, $MOV, $PLAN, $SAFM, $TITN Earnings After the Close: $ADSK, $BOX, $COST, $CRM, $DELL, $DOMO, $GPQ, $HPQ, $KRT, $LGF.A, $OLLI, $ULTA, $VEEV, $VMX, $YEXT Other Key Events: Goldman Sachs TechNet Conference Asia Pacific 2021 (virtual), 5/24-5/28 Microsoft Build Conference (virtual), 5/25-5/27 New Relic Future Stack Conference (virtual), 5/25-5/27 UBS Global Oil & Gas Conference (virtual), 5/25-5/27 Wolfe Research Transport & Industrials Conference (virtual), 5/25-5/27 Cowen Digital Dining Summit (virtual), 5/27 Market Closing Prices Yesterday The S&P 500 Index climbed 7.86 points, or 0.19%, to 4,195.99 The Dow Jones Industrial Average rose 10.59 points, or 0.03%, to 34,323.05 The Nasdaq Composite jumped 80.82 points, or 0.59%, to 13,738.00 The Russell 2000 Index surged 43.52 points, or 1.97% to 2,249.27 Macro Up/Down Last Nymex -0.48 65.73 Brent -0.50 68.37 Gold -1.00 1,895.70 EUR/USD 0.0012 1.2204 JPY/USD 0.02 109.17 10-Year Note +0.012 1.586% Sector News Breakdown Consumer American Eagle ($AEO) 1Q adj EPS $0.48 vs. est. $0.46 on revs $1.03B vs. est. $1.02B, says digital momentum continued with revs +57% (Aerie +158%, AE +20%); total inventory +2% vs 2019 Cavaco Industries ($CVCO) Q4 EPS $2.71 vs. est. $1.92; Q4 revs $306.5M vs. est. $293.79M; home sales order rates improved 50% over last yearโ€™s quarter; backlogs increased $131M during the quarter; Designer Brands ($DBI) 1Q adj EPS $0.12 vs. est. ($0.18) on sales $703.2Mm vs. est. $651Mm, comps +52.2% Elf Beauty ($ELF) Q4 adj EPS $0.71 vs. est. $0.10; Q4 sales $92.7M vs .est. $82.4M; sees 2022 adj EPS 64c-67c vs. est. 71c and sees year revs $343M-$350M vs. est. $334.3M; Q4 Selling, general and administrative expenses rose 23% to $57.9M Modine Manufacturing ($MOD) Q4 adj EPS $1.14 vs. est. $0.27; Q4 sales $514.9M vs. est. $493M; sees full-year 2022 YoY sales up 12%-18% William-Sonoma ($WSM) Q1 adj EPS $2.93 vs. est. $1.83; Q1 revs $1.75B vs. est. $1.52B; Q1 comp brand revenue growth accelerated to 40.4%, with all brands accelerating sequentially including West Elm at 50.9%, Pottery Barn at 41.3%, Williams Sonoma at 35.3% and Pottery Barn Kids and Teen at 27.6%; raising fiscal year 2021 outlook to low double-digit to mid-teen net revenue growth; for long-term, planning for net rev growth of mid-to-high single digits & non-Gaap operating margin expansion Azek ($AZEK) 15M share Secondary priced at $43.50 Crocs Inc. ($CROX) will replace Cantel Medical Corp. ($CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. ($ORGO) will take Crocsโ€™ spot in the S&P SmallCap 600 before trading opens on June 2, according to S&P Dow Jones Indices. Energy, Industrials and Materials Vertex Energy ($VTNR) surged after hours after agreeing to acquire the Mobile refinery in Alabama from Royal Dutch Shell (RDS.A) for $75M Ranpak Holdings ($PACK) 5M share Spot Secondary priced at $21.00 The Department of Homeland Security issued a new security directive for pipeline owners and operators on Thursday after a hack of the Colonial Pipeline disrupted fuel supplies in the southeastern United States for days this month Healthcare Change Healthcare ($CHNG) 4Q adj EPS $0.42 vs. est. $0.36 on revs $855.2Mm vs. est. $840.2Mm; says due to recently announced transaction with Optuminsight, will no longer by providing guidance Ironwood Pharmaceuticals ($IRWD) announces agreement with Teva (TEVA) involving Linzessยฎ (linaclotide) 72 mcg dosage strength Myovant Sciences ($MYOV) and Pfizer ($PFE) receive FDA approval for Myfembreeยฎ, the first once-daily treatment for heavy menstrual bleeding associated with uterine fibroids Nextgen Healthcare ($NXGN) Q4 adj EPS 21c vs. est. 19c; Q4 revs $144.2M vs. est. $140.1M; sees FY22 adj EPS 89c-95c vs. est. 99c; sees FY22 revs $574M-$584M vs. est. $577.2M; Subscription services revenue in Q4 generated $38.2M, or 16% growth over the prior year period, driven by demand for patient experience-related solutions. Day One ($DAWN) 10M share IPO priced at $16.00 Oak Street Health ($OSH)05M share secondary priced at $62.00 Ocugen ($OCGN) says it is on track to submit emergency use authorization application (EUA) to U.S. FDA for its COVID-19 vaccine, Covaxin, in June; awaiting feedback from FDA after master file regarding vaccine was submitted in March R1 RCM ($RCM) 15M share secondary priced at $22.50 Singular Genomics Systems ($OMIC)2M share IPO priced at $22.00 VIR Biotech ($VIR) received FDA emergency use approval for its antibody treatment co-developed with Glaxo ($GSK) to treat mild-to-moderate COVID-19 in people aged 12 years and older Technology, Media & Telecom NVIDIA ($NVDA) Q1 non-Gaap EPS $3.66 vs. est. $3.28; Q1 revs $5.66B vs. est. $5.41B; qtrly data center revenue of $2.05B, up 79% from a year earlier; Q1gaming revenue of $2.76B, up 106% from a year earlier; sees Q2 revs expected to be $6.30B, plus or minus 2% vs. est. $5.5B; Q2 Gaap and non-Gaap gross margins are expected to be 64.6% and 66.5%, respectively, plus or minus 50 bps after Q1 margins 64.1% vs 65.1% YoY and Q1 non-Gaap gross margin 66.2% vs 65.8% YoY Disneyland ($DIS) to allow non-California guests starting on June 15; Disneyland extends reservation window to 120 days DXC Technology ($DXC) Q4 adj EPS 74c vs. est. 70c; Q4 revs $4.385B vs. est. $4.28B; Q4 bookings were $4.7B; sees FY22 adj EPS $3.45-$3.65 vs. est. $3.44; sees FY22 revenue $16.6B-$16.8B vs. est. $16.91B Nutanix ($NTNX) Q3 adj EPS loss (41c) vs. est. loss (49c); Q3 revs $344.5M vs. est. $334.45M; Q3 billings down 3.2% YoY to $371.1M; guides Q4 ACV billings $170M-$175M and Q4 adjusted gross margin roughly 81.5%-82% Okta Inc. ($OKTA) 1Q adj EPS ($0.10) vs. est. ($0.20) on revs $251Mm vs. est. $238.3Mm; guides 2Q adj EPS loss $0.35-0.36 vs. est. loss $0.11, sees 2Q revs $295-297Mm vs. est. $258.2Mm; guides FY adj EPS loss $1.13-1.16 vs. est. loss $0.44, sees FY revs $1.215-1.225B vs. est. $1.09B; says CFO stepping down June 1st, Brett Tighe (Treasurer) will be interim CFO Ooma Inc. ($OOMA) Q1 EPS $0.11c vs. est. $0.08; Q1 revs $45.6M vs. est. $44.31M; sees Q2 EPS 8c-10c vs. est. 6c; guides Q2 revs $46.0M-$46.8M vs. est. $45.12M; sees FY22 EPS 30c-38c vs. est. 29c; sees year revs $185M-$187M vs. est. $183.64M Pure Storage ($PSTG) Q1 adj EPS 0c vs. est. loss (6c); Q1 revs $412.7M vs. est. $403.91M; sees Q2 revs $470M vs. est. $455.85M; sees Q2 non-GAAP operating income $15M; Q1 Subscription services revenue $162.8 million, up 35% YoY; Q1 GAAP gross margin 68.3%; non-GAAP gross margin 70.5% QAD Inc. ($QADA) 1Q EPS $0.09 vs. est. $0.12 on revs $83Mm vs. est. $78.9Mm, subscription revs $36.7Mm; guides 2Q subscription revs $38.5Mm, maintenance revs $26zmm, sees 2Q op income $1Mm incl stock comp exp $5Mm; guides FY subscription revs $160Mm, maintenance revs $102Mm, op inc $12Mm incl stock comp exp $17Mm Snowflake ($SNOW) 1Q EPS ($0.70) vs. est. ($0.16) on revs $228.9Mm vs. est. $212.9Mm, qtr-end total customers were 4,532; guides 2Q product revs $235-240Mm vs. est. $251Mm; guides FY product revs $1.02-1.04B vs. est. $1.09B Workday ($WDAY) 1Q adj EPS $0.87 vs. est. $0.73 on revs $1.18B vs. est. $1.16B, qtrly subscription revs $1.03B +17%; guides 2Q subscription revs $1.095-1.097B; raises FY subscription revs guide to $4.425-$4.44B, raises FY adj op mgn guide to 18-19%; Zuora ($ZUO) 1Q adj EPS ($0.02) vs. est. ($0.04) on revs $80.3Mm vs. est. $79Mm; guides 2Q adj EPS loss $0.04-0.03 vs. est. loss $0.02, sees 2Q revs $82.5-84.5Mm vs. est. $81.8Mm; guides FY adj EPS loss $0.10-0.06 vs. est. loss $0.08, sees FY revs $337-339Mm vs. est. $336.3Mm FIGS ($FIGS)4M share IPO priced at $22.00 Thryv Holdings ($THRY)24M share Secondary priced at $23.50

53 Replies 12 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

it is $OCGN 2.0

65 Replies 9 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

$AMC is officialy an $OCGN styler

96 Replies 8 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@PradeepB #droscrew
recently

MVIS moving up , likely revisit 25-30$ by 6/18 FSR moving up on ocean news FUBO new uptrend confirmed OCGN good to accumulate fib timezone new TOP expected in July

108 Replies 6 ๐Ÿ‘ 12 ๐Ÿ”ฅ

BR
@BrittJ #StockTraders.NET
recently

$OCGN Up a little again

124 Replies 15 ๐Ÿ‘ 6 ๐Ÿ”ฅ

profile
@Math #StockTraders.NET
recently

lol > @maletone said: $OCGN you bitch

79 Replies 15 ๐Ÿ‘ 11 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$OCGN you bitch

85 Replies 11 ๐Ÿ‘ 7 ๐Ÿ”ฅ

BR
@BrittJ #StockTraders.NET
recently

$OCGN covered for now

91 Replies 11 ๐Ÿ‘ 10 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

$OCGN you....

137 Replies 12 ๐Ÿ‘ 12 ๐Ÿ”ฅ

VA
@Valckrie #StockTraders.NET
recently

OCGN goes lower today or tomorrow

135 Replies 7 ๐Ÿ‘ 15 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$FUBO, $PLTR, $OCGN

90 Replies 11 ๐Ÿ‘ 6 ๐Ÿ”ฅ

BR
@brAli #StockTraders.NET
recently

$ocgn nice and strong nate pump

110 Replies 15 ๐Ÿ‘ 7 ๐Ÿ”ฅ

AN
@andres168 #StockTraders.NET
recently

OCGN every going to die? lol

43 Replies 6 ๐Ÿ‘ 13 ๐Ÿ”ฅ

BR
@BrittJ #StockTraders.NET
recently

trying $OCGN again

51 Replies 14 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

I'm out of the $OCGn shorting business

79 Replies 7 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$OCGN needs to clear 9.10's to 9.30s for lower its been tricky

134 Replies 10 ๐Ÿ‘ 15 ๐Ÿ”ฅ

BR
@BrittJ #StockTraders.NET
recently

Wishing I had more size on $OCGN. I don't like to hold size overnight

136 Replies 7 ๐Ÿ‘ 6 ๐Ÿ”ฅ

VA
@Valckrie #StockTraders.NET
recently

wanted OCGN to wait for open

99 Replies 10 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$OCGN quietly

61 Replies 10 ๐Ÿ‘ 15 ๐Ÿ”ฅ

VA
@Valckrie #StockTraders.NET
recently

watching $OCGN for $VXRT type fade today

94 Replies 9 ๐Ÿ‘ 13 ๐Ÿ”ฅ

BR
@BrittJ #StockTraders.NET
recently

Good to know! testing OCGN > @viking said: whoaaa i just found out i dont have to add the $ in front of the ticker..it does it automagically

117 Replies 11 ๐Ÿ‘ 13 ๐Ÿ”ฅ

ST
@stevengo #StockTraders.NET
recently

I'm still short > @xX_Drip_Gawd_Xx said: $OCGN looking strong enough to maybe be a long tomorrow.

68 Replies 12 ๐Ÿ‘ 12 ๐Ÿ”ฅ

profile
@TraderXx #StockTraders.NET
recently

all I know I wont l9ng $OCGN any time soon lol

129 Replies 9 ๐Ÿ‘ 9 ๐Ÿ”ฅ

XX
@xX_Drip_Gawd_Xx #StockTraders.NET
recently

$OCGN looking strong enough to maybe be a long tomorrow.

76 Replies 9 ๐Ÿ‘ 6 ๐Ÿ”ฅ

BR
@BrittJ #StockTraders.NET
recently

back in $OCGN

52 Replies 11 ๐Ÿ‘ 7 ๐Ÿ”ฅ

profile
@maletone #StockTraders.NET
recently

$OCGN mght have double topped

69 Replies 8 ๐Ÿ‘ 9 ๐Ÿ”ฅ

profile
@EricV #ivtrades
recently

holding May12C need move higher > @Carlos-carvan58 said: $OCGN

83 Replies 10 ๐Ÿ‘ 10 ๐Ÿ”ฅ

VA
@Valckrie #StockTraders.NET
recently

OCGN donezo

137 Replies 8 ๐Ÿ‘ 11 ๐Ÿ”ฅ

Key Metrics

Market Cap

1.33 B

Beta

0.73

Avg. Volume

16.89 M

Shares Outstanding

198.23 M

Yield

0%

Public Float

0

Next Earnings Date

2021-08-13

Next Dividend Date

Company Information

Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Its breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug - "one to many" and its novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. The Company is co-developing Bharat Biotech's COVAXINโ„ข vaccine candidate for COVID-19 in the U.S. market.

CEO: Shankar Musunuri

Website:

HQ: 5 Great Valley Pkwy Ste 160 Malvern, 19355 Pennsylvania

Related News

  • FXNews24

    Ocugen (OCGN) Dips More Than Broader Markets: What You Should Know

    31 Jul 2021, 15:49
  • Stocks News Feed

    LAWSUITS FILED AGAINST OCGN, HMPT and ATHA Jakubowitz Law Pursues Shareholders Claims

    31 Jul 2021, 00:38
  • Stock Equity

    Have an eye on: Ocugen, Inc. (NASDAQ:OCGN), Houston American Energy Corp. (AMEX:HUSA)

    30 Jul 2021, 22:35
  • iCrowdNewswire

    Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)

    29 Jul 2021, 17:03
  • Intrado Digital Media

    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ocugen, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action OCGN

    29 Jul 2021, 15:07